1.
Am J Transplant
; 17(1): 292-295, 2017 01.
Article
in English
| MEDLINE
| ID: mdl-27501470
ABSTRACT
The concern about cancer recurrence has traditionally resulted in delaying kidney transplantation for 2-5 years after a cancer diagnosis in patients who are otherwise eligible for transplant. This period of inactive status to observe the tumor biology can result in significant morbidity and decreased quality of life for patients with end-stage renal disease (ESRD). We reported the novel application of genomic profiling assays in breast cancer to identify low-risk cancers in two patients with ESRD who were able to have the mandatory inactive status eliminated prior to kidney transplantation.
Subject(s)
Biomarkers, Tumor/genetics , Breast Neoplasms/pathology , Gene Expression Profiling , Kidney Transplantation , Neoplasm Recurrence, Local/diagnosis , Breast Neoplasms/genetics , Female , Genomics , Humans , Middle Aged , Neoplasm Recurrence, Local/genetics , Prognosis , Risk Factors , Transplant Recipients
2.
Clin Chem
; 36(8 Pt 1): 1519, 1990 Aug.
Article
in English
| MEDLINE
| ID: mdl-2201461